Target
T cell receptor signaling
1 abstract
Abstract
First-line immunochemotherapy modulates peripheral immune landscape in advanced gastric cancer and gastroesophageal junction cancer (GC/GEJC): Prediction of response to combination therapy.Org: The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, Simcere Medical Laboratory Science Co., Ltd.,, State Key Laboratory of Neurology and Oncology Drug Development,